Itai Levi

Summary

Country: Israel

Publications

  1. doi request reprint Low dose palliative radiotherapy for splenomegaly in hematologic disorders
    Konstantin Lavrenkov
    Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 53:430-4. 2012
  2. ncbi request reprint Recurrent pleural effusion as the presenting symptom of autoimmune endocrinopathy type II
    Itai Levi
    Department of Internal Medicine E, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 4:967-8. 2002
  3. ncbi request reprint [Iron-deficiency anemia related to ancylostoma duodenale infection among Ethiopian immigrants to Israel]
    Itai Levi
    Department of Internal Medicine E, Hematology Institute, Soroka Medical Center, Faculty of Health Science, Ben Gurion University of the Negev, Beer Sheba, Israel
    Harefuah 142:606-8, 646. 2003
  4. ncbi request reprint Moderate to severe thrombocytopenia during pregnancy
    Michal Parnas
    Faculty of Health Science, Soroka University Medical Center, Ben Gurion University of the Negev, Be er Sheva, Israel
    Eur J Obstet Gynecol Reprod Biol 128:163-8. 2006
  5. doi request reprint Pregnancy outcome in congenital dyserythropoietic anemia type I
    Hanna Shalev
    Department of Hematology, Soroka Medical Center, Faculty of Medicine, Ben Gurion University of Negev, Beer Sheva, Israel
    Eur J Haematol 81:317-21. 2008
  6. ncbi request reprint Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission
    Itai Levi
    Institute of Hematology, Soroka University Medical Center, PO Box 151, Be er Sheva 84101, Israel
    Leuk Res 28:605-12. 2004
  7. ncbi request reprint Debulking surgery for patients with diffuse large B-cell non-Hodgkin's lymphoma
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 45:1853-6. 2004
  8. doi request reprint High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I
    Hanna Shalev
    Hematology Department, Soroka Medical Center, Faculty of Medicine, Ben Gurion University, Beer Sheva, Israel
    Eur J Haematol 90:31-6. 2013
  9. ncbi request reprint Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Beer Sheva, Israel
    Leuk Lymphoma 45:819-20. 2004
  10. doi request reprint Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma
    Liat Vazana-Barad
    Department of Clinical Biochemistry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 54:851-9. 2013

Collaborators

  • Ofer Shpilberg
  • Hannah Tamary
  • Eyal Sheiner
  • Isaac Ben-Bassat
  • David B Geffen
  • Hanna Shalev
  • Margarita Tokar
  • Liat Vazana-Barad
  • Ronit Yerushalmi
  • Konstantin Lavrenkov
  • Irene Bobilev
  • Joseph Kapelushnik
  • Samuel Ariad
  • Michal Parnas
  • Tikva Yermiahu
  • Elena Israel
  • Aida Inbal
  • Galit Granot
  • Rahav Mor-Tzuntz
  • Dorine W Swinkels
  • Anat Rabinovich
  • Martin Dreyling
  • Carole Brasse-Lagnel
  • Ilana Nathan
  • Galit Perez-Avraham
  • Sari Krepel-Volsky
  • George P Studzinski
  • Victoria Novik
  • Yoav Sharoni
  • Joseph Levy
  • Michael Danilenko
  • Amalia Levy
  • Galit Perez Avraham
  • Reli Hershkovitz
  • Eliezer Burstein
  • Ilana Shoham-Vardi
  • Gershon Holcberg
  • Isaak Yaniv
  • George Shubinsky
  • Boris Rogachev
  • Arnon Nagler
  • Laszlo Muszbek
  • Dmitri Bobilev
  • Levente Karpati
  • Eva Katona
  • Aharon Lubetsky

Detail Information

Publications14

  1. doi request reprint Low dose palliative radiotherapy for splenomegaly in hematologic disorders
    Konstantin Lavrenkov
    Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 53:430-4. 2012
    ..17; p = 0.03; 95% confidence interval 0.035-0.84). In our hands, low dose PSI provided effective palliation for patients with hematologic disorders with SM. Splenic re-irradiation was feasible without excessive toxicity...
  2. ncbi request reprint Recurrent pleural effusion as the presenting symptom of autoimmune endocrinopathy type II
    Itai Levi
    Department of Internal Medicine E, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Isr Med Assoc J 4:967-8. 2002
  3. ncbi request reprint [Iron-deficiency anemia related to ancylostoma duodenale infection among Ethiopian immigrants to Israel]
    Itai Levi
    Department of Internal Medicine E, Hematology Institute, Soroka Medical Center, Faculty of Health Science, Ben Gurion University of the Negev, Beer Sheba, Israel
    Harefuah 142:606-8, 646. 2003
    ..Hookworm infections, caused by the nematodes Necator americanus and Ancylostoma duodenale, involve the gastrointestinal tract, causing iron-deficiency anemia...
  4. ncbi request reprint Moderate to severe thrombocytopenia during pregnancy
    Michal Parnas
    Faculty of Health Science, Soroka University Medical Center, Ben Gurion University of the Negev, Be er Sheva, Israel
    Eur J Obstet Gynecol Reprod Biol 128:163-8. 2006
    ..The objective was to investigate obstetric risk factors, complications, and outcomes of pregnancies complicated by moderate to severe thrombocytopenia...
  5. doi request reprint Pregnancy outcome in congenital dyserythropoietic anemia type I
    Hanna Shalev
    Department of Hematology, Soroka Medical Center, Faculty of Medicine, Ben Gurion University of Negev, Beer Sheva, Israel
    Eur J Haematol 81:317-21. 2008
    ..Moderate to severe maternal anemia is a recognized independent risk factor for low birth weight (LBW) and complicated delivery. The aim of the study was to review the outcome of pregnancies in women with CDA I...
  6. ncbi request reprint Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission
    Itai Levi
    Institute of Hematology, Soroka University Medical Center, PO Box 151, Be er Sheva 84101, Israel
    Leuk Res 28:605-12. 2004
    ..82, 95% CI, 0.71-0.94). In conclusion, ABMT did not improve survival but it improved event-free survival (EFS) when compared with chemotherapy or no further treatment in patients with AML in first complete remission...
  7. ncbi request reprint Debulking surgery for patients with diffuse large B-cell non-Hodgkin's lymphoma
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center and the Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 45:1853-6. 2004
    ..Based on our experience with 2 patients we believe that in specific cases of residual chemo-resistant lymphomatous mass, surgery should be considered as a part of a multimodal approach...
  8. doi request reprint High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I
    Hanna Shalev
    Hematology Department, Soroka Medical Center, Faculty of Medicine, Ben Gurion University, Beer Sheva, Israel
    Eur J Haematol 90:31-6. 2013
    ..Hemojuvelin (HJV) is an important regulator of serum hepcidin, while soluble form of HJV (s-HJV) competitively down-regulates hepcidin...
  9. ncbi request reprint Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys
    Margarita Tokar
    Department of Oncology, Soroka University Medical Center, Beer Sheva, Israel
    Leuk Lymphoma 45:819-20. 2004
    ..The patients renal function improved on therapy, with no need for hemodialysis and there were no significant toxicities. Rituximab may be used as a treatment option for NHL patients with impaired renal function...
  10. doi request reprint Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma
    Liat Vazana-Barad
    Department of Clinical Biochemistry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    Leuk Lymphoma 54:851-9. 2013
    ..The present data indicate that deferasirox, by down-regulating cyclin D1 and inhibiting its related signals, may constitute a promising adjuvant therapeutic molecule in the strategy for MCL treatment...
  11. pmc The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells
    Irene Bobilev
    Department of Clinical Biochemistry, Faculty of Health Sciences, Ben Gurion University of the Negev, Petakh Tikva, Israel
    Cancer Biol Ther 11:317-29. 2011
    ..Our findings suggest that the Nrf2/ARE pathway plays an important part in the cooperative induction of myeloid leukemia cell differentiation by 1,25D and a plant polyphenol...
  12. ncbi request reprint Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow
    Elena Israel
    Flow Cytometry Unit, Soroka University Medical Center, Israel
    Cell Immunol 236:171-8. 2005
    ..e., displayed antigenic properties of early B-cell progenitors. Our data indicate that CD19- early B-cell progenitors in human BM express CD24, and that the expression of CD24 in human B-cell development precedes the expression of CD19...
  13. ncbi request reprint Re: Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis
    Itai Levi
    J Natl Cancer Inst 96:1038-9; author reply 1039-40. 2004
  14. ncbi request reprint Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation
    Aida Inbal
    Institute of Thrombosis and Hemostasis and Bone Marrow Transplantation Department, Sheba Medical Center, Tel Hashomer, and Sackler Faculty of Medicine, Tel Aviv University, Israel
    Blood Coagul Fibrinolysis 15:249-53. 2004
    ..In addition, extra-haematopoietic sources of FXIII synthesis may also contribute to FXIII levels in plasma...